Trials / Unknown
UnknownNCT06296966
A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
A Four-Week, Double-Masked, Randomized, Placebo-Controlled, Phase 2, Evaluation of the Safety and Efficacy of VSJ-110 Ophthalmic Solution in the Treatment of Dry Eye
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VSJ-110 | ophthalmic solution |
| DRUG | Placebo | ophthalmic solution |
Timeline
- Start date
- 2024-02-29
- Primary completion
- 2024-07-01
- Completion
- 2024-07-01
- First posted
- 2024-03-06
- Last updated
- 2024-03-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06296966. Inclusion in this directory is not an endorsement.